Western Wealth Management’s BCE BCE Stock Holding History

Western Wealth Management’s Portfolio BCE Stock Details BCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,775	Closed	-$209K	–	793
2022 Q1	$209K	Buy	+3,775	New	+$200K	0.01%	781

Other funds holding BCE

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Western Wealth Management's BCE Position: Q2 2022 in Review

Western Wealth Management sold out of BCE (BCE) in Q2 2022, closing a stake of 3,775 shares — an estimated $209K sold.

Western Wealth Management first reported a position in BCE in Q1 2022 and held it in 1 quarter. The position peaked at $209K in Q1 2022. 600 funds tracked by Wall St. Rank hold BCE as of Q2 2022.

Western Wealth Management reported no remaining BCE position as of Q2 2022 after selling out during the quarter.
Western Wealth Management sold 3,775 BCE shares in Q2 2022, an estimated $209K.
Western Wealth Management first reported a position in BCE in Q1 2022 and held it in 1 quarter.
Western Wealth Management's BCE position peaked at $209K in Q1 2022.
600 funds tracked by Wall St. Rank held BCE as of Q2 2022.

Based on Western Wealth Management's 13F filing for Q2 2022, filed 18 Jul 2022.